The Paradox of Sirolimus-Induced Immunosuppression and Tumor Control

Publisher： Karger

E-ISSN： 1421-9832|213|1|3-5

ISSN： 1018-8665

Source： Dermatology, Vol.213, Iss.1, 2006-06, pp. : 3-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sirolimus-Induced Acneiform Eruption

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 366-369

Karger

Access to resources Recommend Favorite

Sirolimus-Induced Inflammatory Papules with Acquired Reactive Perforating Collagenosis

By  

Dermatology, Vol. 216, Iss. 3, 2008-01 ,pp. : 239-242

Karger

Access to resources Recommend Favorite

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression

By  

Case Reports in Dermatology, Vol. 2, Iss. 1, 2010-04 ,pp. : 32-35

Karger

Access to resources Recommend Favorite

Melanoma and Immunosuppression

By  

Dermatology, Vol. 218, Iss. 1, 2008-10 ,pp. : 88-88

Karger

Access to resources Recommend Favorite

Angioedema in Renal Transplant Recipients on Sirolimus

By  

Dermatology, Vol. 214, Iss. 3, 2007-03 ,pp. : 205-209

Karger

Access to resources Recommend Favorite